HK23888A - Aqueous suspension of oxendolone - Google Patents
Aqueous suspension of oxendoloneInfo
- Publication number
- HK23888A HK23888A HK238/88A HK23888A HK23888A HK 23888 A HK23888 A HK 23888A HK 238/88 A HK238/88 A HK 238/88A HK 23888 A HK23888 A HK 23888A HK 23888 A HK23888 A HK 23888A
- Authority
- HK
- Hong Kong
- Prior art keywords
- oxendolone
- ester
- suspension
- percent
- aqueous suspension
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56129517A JPS5832899A (ja) | 1981-08-18 | 1981-08-18 | オキセンドロン水性懸濁剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK23888A true HK23888A (en) | 1988-04-08 |
Family
ID=15011450
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK238/88A HK23888A (en) | 1981-08-18 | 1988-03-30 | Aqueous suspension of oxendolone |
Country Status (13)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4120311A1 (de) * | 1991-06-20 | 1992-12-24 | Kali Chemie Pharma Gmbh | Konservierte pharmazeutische zubereitungen |
| US20050032811A1 (en) * | 2003-08-06 | 2005-02-10 | Josiah Brown | Methods for administering aripiprazole |
| JP4836797B2 (ja) * | 2003-10-23 | 2011-12-14 | 大塚製薬株式会社 | 放出制御性無菌注射アリピプラゾール製剤および方法 |
| EP2279727A3 (en) * | 2005-09-15 | 2011-10-05 | Elan Pharma International Limited | Nanoparticulate aripiprazole formulations |
| PL2170279T3 (pl) * | 2007-07-31 | 2018-05-30 | Otsuka Pharmaceutical Co., Ltd. | Sposoby wytwarzania zawiesiny arypiprazolu i liofilizowanej formulacji |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2861920A (en) * | 1954-05-04 | 1958-11-25 | Upjohn Co | Therapeutic suspensions of steroids containing pvp and/or pva |
| US3856829A (en) * | 1970-01-07 | 1974-12-24 | Takeda Chemical Industries Ltd | 16{62 -hydrocarbon substituted estrane compounds |
-
1981
- 1981-08-18 JP JP56129517A patent/JPS5832899A/ja active Granted
-
1982
- 1982-08-06 AR AR290244A patent/AR230730A1/es active
- 1982-08-09 US US06/406,460 patent/US4462996A/en not_active Expired - Lifetime
- 1982-08-11 EP EP82304238A patent/EP0072662B1/en not_active Expired
- 1982-08-11 DE DE8282304238T patent/DE3263754D1/de not_active Expired
- 1982-08-13 GR GR69042A patent/GR76258B/el unknown
- 1982-08-17 KR KR8203686A patent/KR880001806B1/ko not_active Expired
- 1982-08-17 ES ES515057A patent/ES515057A0/es active Granted
- 1982-08-17 CA CA000409562A patent/CA1176983A/en not_active Expired
- 1982-08-17 PT PT75435A patent/PT75435B/pt not_active IP Right Cessation
-
1987
- 1987-12-26 SG SG1101/87A patent/SG110187G/en unknown
- 1987-12-30 MY MY654/87A patent/MY8700654A/xx unknown
-
1988
- 1988-03-30 HK HK238/88A patent/HK23888A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5832899A (ja) | 1983-02-25 |
| DE3263754D1 (en) | 1985-06-27 |
| MY8700654A (en) | 1987-12-31 |
| EP0072662A2 (en) | 1983-02-23 |
| EP0072662A3 (en) | 1983-08-24 |
| US4462996A (en) | 1984-07-31 |
| ES8403719A1 (es) | 1984-04-01 |
| KR880001806B1 (ko) | 1988-09-19 |
| AR230730A1 (es) | 1984-06-29 |
| EP0072662B1 (en) | 1985-05-22 |
| ES515057A0 (es) | 1984-04-01 |
| PT75435A (pt) | 1982-09-01 |
| GR76258B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1984-08-04 |
| PT75435B (pt) | 1985-05-31 |
| CA1176983A (en) | 1984-10-30 |
| JPS6361957B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1988-11-30 |
| SG110187G (en) | 1988-05-20 |
| KR840000901A (ko) | 1984-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5403858A (en) | New compositions containing taxane derivatives | |
| Lorenz et al. | Histamine release in dogs by Cremophor El® and its derivatives: Oxethylated oleic acid is the most effective constituent | |
| DE69413921T2 (de) | Rapamycin-Zubereitungen für die intravenöse Injektion | |
| US5438072A (en) | Taxoid-based compositions | |
| KR860001503B1 (ko) | 이버멕틴의 수용화 방법 | |
| KR870009720A (ko) | 서방형 신규 제약 제제물 | |
| DE2500920A1 (de) | Candicidin enthaltende aerosolschaum- mischung | |
| AU2033300A (en) | Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents | |
| CA1093966A (en) | Instillation composition | |
| EP0667166A1 (en) | Emulsion based on 1-alpha,24-dihydroxy-vitamine d3 | |
| IE49527B1 (en) | Preparing compositions comprising isosorbide dinitrate | |
| EP0072662B1 (en) | Aqueous suspension of oxendolone | |
| EP0689830B1 (en) | Skin cosmetic composition | |
| US5094851A (en) | Water-containing external preparations | |
| JP3523260B2 (ja) | フェンベンダゾール処方物 | |
| IE35203L (en) | Anaesthetic compounds | |
| JP2939082B2 (ja) | 安定なビタミンａパルミテート及びビタミンｅ類可溶化点眼剤 | |
| JP2822058B2 (ja) | 安定な点眼剤 | |
| KR950006218B1 (ko) | 페닐퀴놀린 카복실산의 동결건조 약제 조성물 | |
| EP0452344A1 (de) | Fliessfähige, nichtionische fettstoffdispersion | |
| US4406888A (en) | Aqueous micellar solutions of levonantradol and N-methyllevonantradol and lyophilic forms thereof for reconstitution | |
| JP3438264B2 (ja) | 安定なビタミンａ類可溶化水性点眼剤の調製方法 | |
| JPS6117512A (ja) | 低溶血性ビタミンｅ注射液 | |
| DD153760A5 (de) | Loesungsmittelgemische und verfahren zur herstellung von parenteral verabreichbaren injektionsloesungen | |
| JPH09169642A (ja) | テトラヒドロゾリン含有液剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |